U.S. flag

An official website of the United States government

GRCh37/hg19 15q25.2-25.3(chr15:84827469-85786847)x1 AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Aug 3, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002472536.1

Allele description [Variation Report for GRCh37/hg19 15q25.2-25.3(chr15:84827469-85786847)x1]

GRCh37/hg19 15q25.2-25.3(chr15:84827469-85786847)x1

Genes:
Variant type:
copy number loss
Cytogenetic location:
15q25.2-25.3
Genomic location:
Chr15: 84827469 - 85786847 (on Assembly GRCh37)
Preferred name:
GRCh37/hg19 15q25.2-25.3(chr15:84827469-85786847)x1
HGVS:

    Condition(s)

    Synonyms:
    none provided
    Identifiers:
    MedGen: CN517202

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...

    Assertion and evidence details

    Submission AccessionSubmitterReview Status
    (Assertion method)
    Clinical Significance
    (Last evaluated)
    OriginMethodCitations
    SCV002772404Quest Diagnostics Nichols Institute San Juan Capistrano
    criteria provided, single submitter

    (ACMG/ClinGen CNV Guidelines, 2019)
    Likely pathogenic
    (Aug 3, 2021)
    unknownclinical testing

    PubMed (1)
    [See all records that cite this PMID]

    Summary from all submissions

    EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
    not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

    Citations

    PubMed

    Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen).

    Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, Raca G, Ritter DI, South ST, Thorland EC, Pineda-Alvarez D, Aradhya S, Martin CL.

    Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6. Erratum in: Genet Med. 2021 Nov;23(11):2230. doi: 10.1038/s41436-021-01150-9.

    PubMed [citation]
    PMID:
    31690835
    PMCID:
    PMC7313390

    Details of each submission

    From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV002772404.1

    #EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
    1not providednot providednot providednot providedclinical testing PubMed (1)

    Description

    This deletion interval fully overlaps the 15q25.2q25.3 recurrent region (LCR C-D, distal), which has been observed in individuals with developmental delay and intellectual disability. Case-control studies in children with developmental delay, intellectual disability, multiple congenital anomalies, and other developmental phenotypes showed that heterozygous deletions of this region were enriched in the clinical population (Coe et al., Nat Genet 2014;46(10):1063-71, PMID: 25217958). Additionally, in a large-scale case-control comparison study of copy number variants (CNV) in 15,767 children with developmental delay and intellectual disability, five patients were described with distal microdeletions of 15q25.2q25.3 similar or smaller than the current deletion. Three of these patients were described to have developmental delay (one also had a seizure disorder), one had autism, and one had hypotonia (Cooper et al., Nat Genet 2011 Aug 14;43(9):838-46, PMID: 21841781). Otherwise, heterozygous deletions of this locus have not yet been associated with an established clinical phenotype, and there are two similar copy number losses of this region in the general populations of the Database of Genomic Variants. Thus, conservatively, the clinical significance of this recurrent region is regarded as likely pathogenic.

    #SampleMethodObservation
    OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
    1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

    Last Updated: Dec 31, 2022